Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Navkar Corporation Ltd
NSE:NAVKARCORP
|
IN |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Short-Term Debt
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Short-Term Debt
¥831.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
49%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Short-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Short-Term Debt
¥68.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
20%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Short-Term Debt
¥311.5m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-9%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Short-Term Debt
¥675.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Short-Term Debt
¥603.8m
|
CAGR 3-Years
49%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View
Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., nestled in the heart of Fujian Province, China, is a firm steeped in history and tradition, yet thriving in today’s modern pharmaceutical landscape. The company is best known for its signature product, Pientzehuang Pills, a centuries-old traditional Chinese medicine believed to offer hepatoprotective and detoxifying properties. Rooted in ancient formulations, Pientzehuang Pills are celebrated for their efficacy in addressing liver ailments and enhancing overall vitality. This has secured their place as a staple in Chinese households, maintaining cultural resonance while appealing to a broader audience through the global rise in demand for alternative medicine. The firm operates with a delicate balance, integrating traditional Chinese medicine practices with increasingly sophisticated production technologies to ensure quality consistency and scalability. Zhangzhou Pientzehuang leverages its brand heritage and expertise in traditional herbal remedies to drive revenue. The company has adeptly positioned itself within both domestic and international markets, capitalizing on the growing interest in holistic health approaches. By focusing on research and development, the company continues to innovate, expanding its product line to include health supplements and preventive solutions that cater to modern health challenges. Its strategic distribution channels, including hospitals, pharmacies, and online platforms, enable broad market penetration, ensuring robust sales growth. This dual strategy of preserving the traditional while embracing the modern allows the company to keep its legacy relevant in a competitive pharmaceutical industry, thereby securing its stronghold in the market and ensuring sustained financial performance.
See Also
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Short-Term Debt?
Short-Term Debt
831.9m
CNY
Based on the financial report for Sep 30, 2025, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Short-Term Debt amounts to 831.9m CNY.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
49%
Over the last year, the Short-Term Debt growth was -15%. The average annual Short-Term Debt growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been -2% over the past three years , 3% over the past five years , and 49% over the past ten years .